Drugs that target the GLP-1 (glucagon-like peptide-1) receptor, sometimes referred to as GLP-1 receptor agonists, have long been authorized for the treatment of type 2 diabetes
Preventive strategies include gradual weight loss when medically appropriate, adequate protein intake to support collagen synthesis, hydration, and sun protection
Although metformin and Ozempic aren't prescribed for weight loss, both medicines can cause you to lose weight
Month 4 through month 6: the transformation deepens Months four through six represent the heart of the GLP-1 transformation
Because that concept, scientifically, made sense, the compound advanced into human clinical trials
Mounjaro (tirzepatide) EPAR Assessment Report